Showing 501-510 of 856 results for "".
- Thermi Receives Health Canada Clearance to Market Thermi RF for Dermal Laxityhttps://modernaesthetics.com/news/there-receives-health-canada-clearance-to-market-thermi-rf-for-dermal-laxity/2472079/Therm
- Back by Popular Demand: Sciton's Bright Lights Big City BBL Tourhttps://modernaesthetics.com/news/back-by-popular-demand/2472107/Sciton. Inc.’s
- Revance, Mylan Partner to Develop Botox Biosimilarhttps://modernaesthetics.com/news/revance-mylan-partner-to-develop-botox-biosimilar/2472123/Mylan N.V. and
- Milestone Scientific Gears Up To Launch New Botox Delivery Instrumenthttps://modernaesthetics.com/news/milestone-scientific-gears-up-to-launch-new-botox-delivery-instrument/2472162/Botulinum toxin injections may be about to get smarter and more comfortable as Milestone Scientific Inc. readies to launch its novel and proprietary cosmetic injection instrument. The new cosmetic injection instrument
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Study: CINDR of Masseter Muscle Optimal Injection Site for Botoxhttps://modernaesthetics.com/news/study-cindr-of-masseter-muscle-optimal-injection-site-for-botox/2475664/Research published in the Annals of Anatomy journal indicates the center of the intramuscular nerve dense region (CINDR) of the masseter muscle as the optimal botulinum neurotoxin A (BoNT-A) injection site. The researchers used 60 rabbits to assess BoNT-A injection efficacy at the CINDR.<
- LevEllis Launches Regenerative Serum Featuring Skin-Specific Secretome Technologyhttps://modernaesthetics.com/news/levellis-launches-regenerative-serum-featuring-skin-specific-secretome-technology/2475660/LevEllis, Inc. announced the launch of PROVOQUE™, a physician-dispensed regenerative skincare serum formulated with a proprietary skin-specific secretome. Developed by surgeon and molecular biologist Laura Ellis, MD, the product represents a new approach in medical-grade skincare by delivering a
- New Research Evaluates Nonsurgical Rhinoplasty Using HA Filler in Asian Patientshttps://modernaesthetics.com/news/new-research-evaluates-nonsurgical-rhinoplasty-using-ha-filler-in-asian-patients/2475629/Newly published data in the Plastic and Aesthetic Nursing journal indicates the anatomical and procedural nuances that are critical for achieving optimal results in nonsurgical rhinoplasty (NSR) using hyaluronic acid (HA) dermal filler. Authors Jovian Wan, MBChB, and Kyu-Ho Yi, MD, PhD,
- Sinclair North America Introduces Inaugural Advisory Boardhttps://modernaesthetics.com/news/sinclair-north-america-introduces-inaugural-advisory-board/2475577/Sinclair North America announced its inaugural Advisory Board, consisting of 16 plastic surgeons, dermatologists, aesthetic practitioners, and aestheticians. The board will advance Sinclair North America’s mission of delivering a timeless and trending portfolio of clinically-validated prod